Contact Us: 1-888-667-3325 / customerservice@thedeal.com

Subscriber Content Preview | Request a free trialSearch  
  Go

Regulatory

Obamacare ruling expected to intensify healthcare M&A

Hospitals, REITs and insurers are likely to benefit from the Supreme Court's decision in King v. Burwell. Continue reading

What Boeing's new CEO must do to push the aerospace giant higher

Dennis Muilenberg, a 30-year company veteran, inherits surging commercial sales but faces a challenge with the defense business. Meeting it might entail testing the Pentagon's stance against big mergers. Continue reading

CVS builds a muscular stake in Medicare

Deal will grow CVS Health's MinuteClinic walk-in clinic franchises and provide Target customers with expanded pharmacy care programs. Continue reading

Negotiating a solution for NECC and fungal meningitis victims

Paul Moore, the Chapter 11 trustee for the Boston pharmacy company, reflects on how the $200 million settlement came to be for those killed and infected during the historic outbreak. Continue reading

Why Syngenta is right about the risks of Monsanto's offer

Antitrust experts say a merger can get approved but the DOJ would conduct a long review and insist upon a complicated divestiture package involving multiple buyers. Continue reading

In its Steris challenge, the FTC sees through Synergy Health's big X-ray sterilization plans

The British target was intending to invade the U.S. market with new technology that would have disrupted its merger partner's business. Those designs now imperil the $1.9 billion deal. Continue reading

Adam Gottbetter, securities lawyer, reverse merger adviser, sentenced to 1.5 years for conspiracy

The founder of Gottbetter & Partners, Gottbetter Capital and Gottbetter Capital Markets also agreed to pay $4.6 million in a settlement with the SEC. Continue reading

After lengthy pursuit, Malone and Charter reach $78.7 billion Time Warner Cable deal

Charter will also roll up Bright House Networks. Continue reading

China Inc. goes private -- one mediocre piece at a time

Beijing's restructuring of state-owned enterprises will generate some opportunities for foreign investors, but in a seller's market the government is always looking out mainly for itself. Continue reading

Europe sets conditions for Mondelez, D.E. Master Blenders to blend their coffees

The U.S. and Dutch coffee joint venture gets European regulators' approval, but the companies must sell brands to caffeinate competition in the region. Continue reading

Applied Materials, Tokyo Electron abandon merger plan

Both companies plan to embark on share buybacks after Justice Department objections smothered the 19-month-old agreement. Continue reading

For Teva, poison pills and regulatory worries won't stop the march on Mylan

The generics giant's offer is contingent on the target dropping its own offer for Perrigo, which right now will be a tough sell to its shareholders. Continue reading

Meet the journalists

William McConnell

Assistant Managing Editor: Regulatory & Arbitrage

Corinthian Colleges and the history of for-profit education crackdowns

The Nasdaq is delisting shares of for-profit educator Corinthian Colle ... Video

More Regulatory video

The Deal's Webcast Series

If you have not had the chance to enjoy our Webcast Series, now is the time. Join these free 60-minute discussions and get a handle on the latest strategies and tactics in private equity, cross-border and middle market dealmaking and more.

Industry Events

View information on all upcoming industry events which The Deal representatives are participating in.

The Deal Economy Event

Our senior journalists host the industry's leading forecasting event, where influential members of the deal community discuss the outlook for dealmaking.

The Deal on Twitter

Follow @TheDealNewsroom for the latest news across mergers and acquisitions, auctions, financings, restructurings and more!